Funding Details
- Awarder
- Inbox
- Date Award
- April 28, 2025
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
-
$150,000,000
Company Info
- Founding Year
- None
- Traction
- Monte Rosa is responsible for the ongoing Phase 1 clinical study of MRT-6160 and will co-fund any Phase 3 clinical development.
- Organizations Involved
- Novartis
- Founders
- None
- Company Description
- Monte Rosa Therapeutics is a biotechnology company that develops cancer therapeutics that modulate protein degradation pathways.
- Market
- Oncology, Autoimmune and Inflammatory Diseases
- Location
-
Boston,
MA,
US
- Coinvestors
- Novartis
Links